• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 in 2022-The Beginning of the End or the End of the Beginning?

作者信息

Del Rio Carlos, Malani Preeti N

机构信息

Division of Infectious Diseases, Department of Internal Medicine, Emory University School of Medicine, Atlanta, Georgia.

Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Georgia Grady Health System, Atlanta.

出版信息

JAMA. 2022 Jun 28;327(24):2389-2390. doi: 10.1001/jama.2022.9655.

DOI:10.1001/jama.2022.9655
PMID:35622357
Abstract
摘要

相似文献

1
COVID-19 in 2022-The Beginning of the End or the End of the Beginning?2022年的新冠疫情——是结束的开始还是开始的结束？
JAMA. 2022 Jun 28;327(24):2389-2390. doi: 10.1001/jama.2022.9655.
2
Iterative data-driven forecasting of the transmission and management of SARS-CoV-2/COVID-19 using social interventions at the county-level.基于县级社会干预的 SARS-CoV-2/COVID-19 传播和管理的迭代数据驱动预测。
Sci Rep. 2022 Jan 18;12(1):890. doi: 10.1038/s41598-022-04899-4.
3
[Analysis and future scenarios of the SARS-CoV-2 epidemic in Tuscany Region (Central Italy)].[意大利中部托斯卡纳地区新冠病毒疫情分析与未来情景]
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):120-127. doi: 10.19191/EP20.5-6.S2.110.
4
Nowcasting the spread of SARS-CoV-2.新型冠状病毒肺炎（SARS-CoV-2）传播的即时预报
Nat Microbiol. 2022 Jan;7(1):16-17. doi: 10.1038/s41564-021-01035-2.
5
A forecasting model to estimate the drop in blood supplies during the SARS-CoV-2 pandemic in Italy.用于估计 SARS-CoV-2 大流行期间意大利血液供应下降的预测模型。
Transfus Med. 2021 Jun;31(3):200-205. doi: 10.1111/tme.12764. Epub 2021 Mar 10.
6
Coronavirus disease 2019 (COVID-19) outbreak in Afghanistan: Measures and challenges.2019年冠状病毒病（COVID-19）在阿富汗的爆发：措施与挑战。
Infect Control Hosp Epidemiol. 2021 Mar;42(3):366-367. doi: 10.1017/ice.2020.240. Epub 2020 May 15.
7
Infection with SARS-CoV-2 is not the same as covid-19.感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）与冠状病毒病19（COVID-19）并不相同。
BMJ. 2021 Aug 2;374:n1896. doi: 10.1136/bmj.n1896.
8
Myeloma care adaptations in the UK during SARS-CoV-2 pandemic: Challenges and measurable outcomes.英国在新冠疫情期间骨髓瘤护理的调整：挑战与可衡量的结果
Eur J Haematol. 2020 Nov;105(5):662-666. doi: 10.1111/ejh.13479. Epub 2020 Jul 15.
9
Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021.2020 年 10 月至 2021 年 3 月意大利流行的 SARS-CoV-2 变异株。
Virol J. 2021 Aug 14;18(1):168. doi: 10.1186/s12985-021-01638-5.
10
Forecasting emergence of COVID-19 variants of concern.预测 COVID-19 关注变种的出现。
PLoS One. 2022 Feb 24;17(2):e0264198. doi: 10.1371/journal.pone.0264198. eCollection 2022.

引用本文的文献

1
The Challenge of Long COVID: Is the Pandemic Really Over?长新冠的挑战：疫情真的结束了吗？
Public Health Rep. 2025 Aug 17:333549251358665. doi: 10.1177/00333549251358665.
2
Immunogenicity, clinical efficacy, and safety of the sinopharm (BBIBP-CorV) SARS-CoV-2 vaccine among people with multiple sclerosis receiving disease-modifying therapies: a prospective cohort study.在接受疾病修正治疗的多发性硬化症患者中，国药（BBIBP-CorV）SARS-CoV-2 疫苗的免疫原性、临床疗效和安全性：一项前瞻性队列研究。
BMC Neurol. 2024 Aug 20;24(1):291. doi: 10.1186/s12883-024-03793-y.
3
Insight into genomic organization of pathogenic coronaviruses, SARS-CoV-2: Implication for emergence of new variants, laboratory diagnosis and treatment options.
深入了解致病性冠状病毒SARS-CoV-2的基因组组织：对新变种出现、实验室诊断和治疗选择的启示
Front Mol Med. 2022 Oct 17;2:917201. doi: 10.3389/fmmed.2022.917201. eCollection 2022.
4
Design of multi-epitope chimeric vaccine against Monkeypox virus and SARS-CoV-2: A vaccinomics perspective.针对猴痘病毒和 SARS-CoV-2 的多表位嵌合疫苗设计：疫苗组学视角。
J Cell Mol Med. 2024 May;28(10):e18452. doi: 10.1111/jcmm.18452.
5
The effect of immunosuppressive therapies on the endothelial host response in critically ill COVID-19 patients.免疫抑制疗法对危重症 COVID-19 患者内皮固有宿主反应的影响。
Sci Rep. 2024 Apr 20;14(1):9113. doi: 10.1038/s41598-024-59385-w.
6
Evaluating the spike in the symptomatic proportion of SARS-CoV-2 in China in 2022 with variolation effects: a modeling analysis.基于人痘接种效应评估2022年中国新冠病毒有症状感染比例的激增：一项建模分析
Infect Dis Model. 2024 Mar 11;9(2):601-617. doi: 10.1016/j.idm.2024.02.011. eCollection 2024 Jun.
7
Surveillance of laboratory exposures to human pathogens and toxins, Canada, 2022.2022年加拿大实验室人员接触人类病原体和毒素情况监测
Can Commun Dis Rep. 2023 Sep 1;49(9):398-405. doi: 10.14745/ccdr.v49i09a06.
8
COVID-19 Linked Social Stigma Among Arab Survivors: A Cross-Sectional Experiences from the Active Phase of the Pandemic.新冠疫情期间阿拉伯幸存者中与COVID-19相关的社会污名：大流行活跃期的横断面经历
J Multidiscip Healthc. 2024 Feb 26;17:805-823. doi: 10.2147/JMDH.S450611. eCollection 2024.
9
Exploration of P1 and P4 modifications of nirmatrelvir: Design, synthesis, biological evaluation, and X-ray structural studies of SARS-CoV-2 Mpro inhibitors.探索奈玛特韦的 P1 和 P4 修饰：SARS-CoV-2 Mpro 抑制剂的设计、合成、生物学评价和 X 射线结构研究。
Eur J Med Chem. 2024 Mar 5;267:116132. doi: 10.1016/j.ejmech.2024.116132. Epub 2024 Feb 1.
10
COVID-19 and cardiovascular complications: updates of emergency medicine.新型冠状病毒肺炎与心血管并发症：急诊医学的最新进展
Emerg Crit Care Med. 2023 Sep;3(3):104-114. doi: 10.1097/ec9.0000000000000095. Epub 2023 Jun 1.